Current Oncology

Established in 1994, Current Oncology is a peer-reviewed, Canadian based and Internationally distributed journal. Published bi-monthly plus special supplemental issues, Current Oncology represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy to report upon and to review progress in the management of this disease. Current Oncology is published by Multimed Inc.

Current Oncology is indexed/covered in PubMed, EMBASE (Excerpta Medica Database), Scopus, Journal Selector, Crossref, Index Copernicus, DOAJ (Directory of Open Access Journals), Google Scholar, EMCare, EBSCOhost.com Research Databases, Science Citation Index Expanded (SciSearch), and Journal Citation Reports/Science Edition. Following publication in Current Oncology, the full text of each article is available immediately and archived in PubMed Central (PMC), the U.S. National Library of Medicine's digital archive of biomedical and life sciences journal literature. It is also available in the databases of 100 libraries worldwide, and is a participant of the HINARI program.



The information provided on the Current Oncology website is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.

Announcements

 

Publish with Current Oncology - Article Collections, Series, and Supplemental Issues

 

As Canada’s premier Oncology journal, we invite cancer agencies, organizations and researchers from across Canada to publish with Current Oncology. The journal provides an excellent venue and opportunity to increase the visibility of your studies and investigations to members of the Canadian Oncology community. Publishing in an established journal with a well-developed readership, is an excellent way to reach your key audience. It also keeps the community informed of ongoing work in the field, as well as important research and findings that have a clear potential for application to the current and future practice of cancer medicine in Canada.

For more information about publishing with Current Oncology go to: 

http://www.current-oncology.com/pages/files/supplement_promo.pdf 

 
Posted: 2017-11-14
 

Job Posting: Career Opportunity in Palliative Medicine

 

William Osler Health System (Osler) is one of Ontario’s largest community hospital organizations, delivering innovative health care with compassion through more than 650,000 patient interactions every year. With three hospital sites: Brampton Civic Hospital, Etobicoke General Hospital and the new Peel Memorial Centre for Integrated Health and Wellness. We offer a wide range of health services, with care provided by skilled health professionals working in multidisciplinary teams.

We are recruiting physicians with a passion for palliative care to join our dedicated and growing Palliative Care Program at William Osler Health System. Interested candidates would be part of the interdisciplinary team working with both hospital and community providers.  Osler is a distributive campus for the McMaster Family Medicine Training program with 20 residents on site and active opportunities to teach undergraduate and postgraduate learners in Palliative Care as part of a collaborative faculty. It’s an officially designated site for the training of the Royal College sub-speciality in Palliative Medicine

The successful applicants must be licensed to practice in Ontario and hold a Fellowship from the Royal College of Physicians and Surgeons of Canada or a Certification in Family Medicine from the College of Family Physicians of Canada.  A certificate of added competency training and experience in Palliative Medicine is a requirement. 

Expressions of interest should be forwarded along with your curriculum vitae to:

Medical Staff Office

Attention: Dr. Martin Chasen, Medical Director of Palliative Care

William Osler Health System

2100 Bovaird Drive East, Brampton, ON   L6R 3J7

Tel: (905) 494-2120    Fax: (905) 494-6206  

Email: mso.credentialing@williamoslerhs.ca

 
Posted: 2017-08-02 More...
 

Journal Announcement: New Impact Factor of 2.048 for Current Oncology!

 

We are pleased to announce to our readers that Current Oncology’s 2016 Impact Factor has increased to 2.048! This is an increase from our 2015 stats, where we received an impact factor of 1.829.

The journal impact factor is a measure of citation frequency that reflects the average number of citations to articles published in science and social science journals. Impact factors are calculated annually for those journals that are indexed in Thomson Reuters Journal Citation Reports. The impact factor of a journal in a given year is the average number of citations a paper published in that journal received during the two previous years. The impact factor is often used to rank the relative importance and scientific caliber of a journal within its field.

Our 2016 Impact Factor is a significant achievement for the journal, and demonstrates the increased recognition of Current Oncology in the field, and the improved relevance and quality of our articles. Thank you to our team of Editors and Section Editors, Reviewers and Authors for their valuable contribution to the journal. We look forward to continued success in 2017 as the journal continues to strengthen and grow!

Multimed Inc.
Publisher of Current Oncology

 
Posted: 2017-06-29 More...
 
More Announcements...

Vol 24, No 5 (2017)

Table of Contents

Editorial(s)

Commentary(ies)

Original Article(s)

Cancer Rehabilitation and Survivorship

D. Santa Mina, D. Au, J. Brunet, J. Jones, G. Tomlinson, N. Taback, D. Field, A. Berlingeri, H. Bradley, D. Howell
284-294
Y. Yuan, J. Ross, Q. Shi, F.G. Davis
e341-e347
W. Law, C. Johnson, M. Rushton, S. Dent
e348-e353

Medical Economics

G.N. Honein-AbouHaidar, J.S. Hoch, M.J. Dobrow, T. Stuart-McEwan, D.R. McCready, A.R. Gagliardi
e354-e360

Medical Oncology

A. Srikanthan, H. Mai, N. Penner, E. Amir, A. Laupacis, M. Sabharwal, K.K.W. Chan
295-301
G. Kasymjanova, D. Small, V. Cohen, R.T. Jagoe, G. Batist, W. Sateren, P. Ernst, C. Pepe, L. Sakr, J. Agulnik
302-309
W.M. Jose, K. Pavithran, T.S. Ganesan
e361-e367
M.B. Hannouf, E. Winquist, S.M. Mahmud, M. Brackstone, S. Sarma, G. Rodrigues, P.K. Rogan, J.S. Hoch, G.S. Zaric
e368-e378

Radiation Oncology

T.A. Koulis, K. Beecham, C. Speers, S. Tyldesley, D. Voduc, C. Simmons, R. Olson
310-317
X.M. Qu, J.J. Biagi, W.M. Hopman, A. Mahmud
e379-e387

Surgical Oncology

J.S. Lam, G.M. Scott, D.A. Palma, K. Fung, A.V. Louie
318-323
E.C. McKevitt, C.K. Dingee, R. Warburton, J.S. Pao, C.J. Brown, C. Wilson, U. Kuusk
e388-e393
J. Maxwell, A. Aranaout, R. Hanrahan, M. Brackstone
e394-e402

Practice Guideline(s)

N. Coburn, R. Cosby, L. Klein, G. Knight, R. Malthaner, J. Mamazza, C.D. Mercer, J. Ringash
324-331
M.C. Chang, L.H. Souter, S. Kamel-Reid, M. Rutherford, P. Bedard, M. Trudeau, J. Hart, A. Eisen, and the Molecular Oncology Advisory Committee
e403-e422

Short Communication(s)

A.C. Coronado, K. Tran, J. Chadder, J. Niu, S. Fung, C. Louzado, R. Rahal, in collaboration with the System Performance Steering Committee and the Technical Working Group
332-337

Case Report(s)

M. Flader, P. Kurzawa, J. Maldyk, J. Sygut, J. Harasymczuk, A. Kropinska, D. Handkiewicz-Junak, B. Jarzab, K. Kotulska, M. Niedziela
e423-e428
E. Hendren, O. Vinik, H. Faragalla, R. Haq
e429-e433
D.M. Betsch, S. Gray, S.E. Zed
e434-e437

Cancer Narratives: Words Beyond Disease

S. Lalani
338
A. Arnaout, A.A. Joy, M. Juliao, M. Clemons
e437-e440